| ABIRATERONE AND METHYLPREDNISOLONE |
Yonsa Mpred® |
Sun Pharma ANZ Pty Ltd |
Prostate cancer |
Nov 2022 |
|
| ADALIMUMAB UPADACITINIB |
Humira®Rinvoq® |
AbbVie Pty Ltd |
All adalimumab indications except juvenile idiopathic arthritis.Severe active rheumatoid
arthritis. |
Nov 2022 |
|
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE |
PKU Squeezie® |
Vitaflo Australia Pty Limited |
Phenylketonuria |
Nov 2022 |
|
| AMINO ACID SYNTHETIC FORMULA SUPPLEMENTED WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS,
MEDIUM CHAIN TRIGLYCERIDES AND 2- FUCOSYLLACTOSE AND LACTO-N-NEOTETRAOSE |
Alfamino® |
Nestle Australia Ltd |
Cows' milk protein enteropathy;Severe cows' milk protein enteropathy with failure
to thrive;Combined intolerance to cows' milk protein, soy protein and protein hydrolysate
formulae;Cows' milk anaphylaxis;Proven combined immunoglobulin E (IgE) mediated allergy
to cows' milk protein and soy protein;Severe intestinal malabsorption including short
bowel syndrome;Eosinophilic oesophagitis. |
Nov 2022 |
|
| ASCIMINIB |
Scemblix® |
Novartis Pharmaceuticals Australia Pty Limited |
Chronic myeloid leukaemia |
Nov 2022 |
|
| AVATROMBOPAG |
Doptelet® |
Swedish Orphan Biovitrum Pty Ltd |
Chronic immune (idiopathic) thrombocytopenia purpura |
Nov 2022 |
|
| BUDESONIDE WITH GLYCOPYRRONIUM AND FORMOTEROL |
Breztri Aerosphere® DFP-EvoCap |
AstraZeneca Pty Ltd |
Chronic obstructive pulmonary disease |
Nov 2022 |
|
| DAROLUTAMIDE |
Nubeqa® |
Bayer Australia Ltd |
Prostate cancer |
Nov 2022 |
|
| DEUCRAVACITINIB |
Sotyktu® |
Bristol-Myers Squibb Australia Pty Ltd |
Plaque psoriasis |
Nov 2022 |
|
| DOSTARLIMAB |
Jemperli® |
GlaxoSmithKline Australia Pty Ltd |
Endometrial cancer |
Nov 2022 |
|
| DULAGLUTIDE |
Trulicity (Netherlands) |
Medsurge Healthcare Pty Ltd |
Type 2 diabetes mellitus (T2DM) |
Nov 2022 |
|
| DUPILUMAB |
Dupixent® |
sanofi-aventis Australia Pty Ltd |
Chronic severe atopic dermatitis;Uncontrolled severe asthma. |
Nov 2022 |
|
| ELEXACAFTOR WITH TEZACAFTOR AND WITH IVACAFTOR, AND IVACAFTOR |
Trikafta® |
Vertex Pharmaceuticals (Australia) Pty. Ltd. |
Cystic fibrosis |
Nov 2022 |
|
| EMPAGLIFLOZIN |
Jardiance® |
Boehringer Ingelheim Pty Ltd |
Chronic heart failure |
Nov 2022 |
|
| ENFORTUMAB VEDOTIN |
Padcev® |
Astellas Pharma Australia Pty Ltd |
Urothelial cancer |
Nov 2022 |
|
| ETANERCEPT |
Nepexto® |
Alphapharm Pty Ltd |
Rheumatoid arthritis;Juvenile idiopathic arthritis;Psoriatic arthritis;Plaque psoriasis;Ankylosing
spondylitis. |
Nov 2022 |
|
| FREMANEZUMAB |
Ajovy® |
Teva Pharma Australia Pty Ltd |
Migraine |
Nov 2022 |
|
| GLYCOMACROPEPTIDE FORMULA WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS AND DOCOSAHEXAENOIC
ACID AND LOW IN PHENYLALANINE |
PKU Sphere Liquid |
Vitaflo Australia Pty Limited |
Phenylketonuria |
Nov 2022 |
|
| INFLIXIMAB |
Remsima® SC |
Celltrion Healthcare Australia Pty Ltd |
Rheumatoid arthritis |
Nov 2022 |
|
| LANREOTIDE |
Mytolac® |
Amdipharm Mercury (Australia) Pty Limited |
Acromegaly;Functional carcinoid tumour;Non-functional gastroenteropancreatic neuroendocrine
tumour (GEP-NET). |
Nov 2022 |
|
| LENACAPAVIR |
Sunlenca® |
Gilead Sciences Pty Limited |
Human immunodeficiency virus infection |
Nov 2022 |
|
| MAVACAMTEN |
Camzyos® |
Bristol-Myers Squibb Australia Pty Ltd |
Hypertrophic cardiomyopathy |
Nov 2022 |
|
| MEPOLIZUMAB |
Nucala® |
GlaxoSmithKline Australia Pty Ltd |
Chronic rhinosinusitis with nasal polyps |
Nov 2022 |
|
| MIDAZOLAM |
Zyamis® |
Clinect Pty Ltd |
Epilepsy |
Nov 2022 |
|
| MOBOCERTINIB |
Exkivity® |
Takeda Pharmaceuticals Australia Pty. Ltd. |
Non-small cell lung cancer |
Nov 2022 |
|
| NIVOLUMAB |
Opdivo® |
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Oesophageal carcinoma or gastroesophageal junction carcinoma |
Nov 2022 |
|
| NIVOLUMAB PLUS IPILIMUMAB |
Opdivo® Yervoy® |
Bristol-Myers Squibb Australia Pty Ltd |
Melanoma |
Nov 2022 |
|
| OLAPARIB |
Lynparza® |
AstraZeneca Pty Ltd |
Ovarian cancer |
Nov 2022 |
|
| ONASEMNOGENE ABEPARVOVEC |
Zolgensma® |
Novartis Pharmaceuticals Australia Pty Limited |
Spinal muscular atrophy |
Nov 2022 |
|
| OZANIMOD |
Zeposia® |
Celgene Pty Limited |
Ulcerative colitis |
Nov 2022 |
|
| PATIROMER |
Veltassa® |
Vifor Pharma Pty Limited |
Hyperkalaemia |
Nov 2022 |
|
| PEMBROLIZUMAB |
Keytruda® |
MERCK SHARP & DOHME (AUSTRALIA) PTY LTD |
Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer |
Nov 2022 |
|
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Cervical cancer |
Nov 2022 |
|
| PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE |
Prevenar 20® |
Pfizer Australia Pty Ltd |
Pneumococcal disease |
Nov 2022 |
|
| POLATUZUMAB VEDOTIN |
Polivy® |
Roche Products Pty Ltd |
Diffuse large B-Cell lymphoma |
Nov 2022 |
|
| RISANKIZUMAB |
Skyrizi® |
AbbVie Pty Ltd |
Crohn Disease |
Nov 2022 |
|
| RISEDRONIC ACID |
Actonel® EC |
Theramex Australia Pty Ltd |
Osteoporosis |
Nov 2022 |
|
| RUXOLITINIB |
Jakavi® |
Novartis Pharmaceuticals Australia Pty Limited |
Chronic Graft vs Host Disease |
Nov 2022 |
|
| SELINEXOR |
Xpovio® |
ANTENGENE (AUS) PTY. LTD. |
Multiple myeloma |
Nov 2022 |
|
| SELUMETINIB |
Koselugo® |
Alexion Pharmaceuticals Australasia Pty Ltd |
Neurofibromatosis type 1 (NF1) |
Nov 2022 |
|
| SEMAGLUTIDE |
Ozempic® (UK) |
Medsurge Healthcare Pty Ltd |
Type 2 diabetes mellitus (T2DM) |
Nov 2022 |
|
| UPADACITINIB |
Rinvoq® |
ABBVIE PTY LTD |
Ulcerative colitis |
Nov 2022 |
|
| UPADACITINIB |
Rinvoq® |
ABBVIE PTY LTD |
Non-radiographic axial spondyloarthritis |
Nov 2022 |
|
| VOSORITIDE |
Voxzogo® |
BioMarin Pharmaceutical Australia Pty Ltd |
Achondroplasia |
Nov 2022 |
|